PLRZ Secures First U.S. Clinical Site for NASARIX Allergy Blocker, Initiates Multi‑Center Trial
Polyrizon Ltd. Ordinary Shares · Now $15.41
+1.5% since the alert
$15.18 → $15.41
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS